CHINET 2010 surveillance and analysis of antibiotic resistance in Staphylococcus spp. in China

Chinese Journal of Infection and Chemotherapy

Volumn 13, Issue 2, 2013, Pages 86-92

  Guo, Yan ^a,b   Zhu, Demei ^a,b   Hu, Fupin ^a,b   Wang, Fu ^a,b   Yu, Yunsong ^a,b   Yang, Qing ^a,b   Zhang, Hong ^a,b   Kong, Jing ^a,b   Wang, Chuanqing ^a,b   Wang, Aimin ^a,b   Hu, Yunjian ^a,b   Ai, Xiaoman ^a,b   Sun, Ziyong ^a,b   Chen, Zhongju ^a,b   Ni, Yuxing ^a,b   Sun, Jingyong ^a,b   Xu, Yuanhong ^a,b   Shen, Jilu ^a,b   Shan, Bin ^a,b   Du, Yan ^a,b   Zhang, Zhaoxia ^a,b   Ji, Ping ^a,b   Xu, Yingchun ^a,b   Sun, Hongii ^a,b   Wei, Lianhua ^a,b   Wu, Ling ^a,b   Su, Danhong ^a,b   Zhuo, Chao ^a,b   Jia, Bei ^a,b   Huang, Wenxiang ^a,b   more..

^a FUDAN UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Antibiotic resistance; Antimicrobial agent; Antimicrobial susceptibility testing; Staphylococcus

Indexed keywords

COTRIMOXAZOLE; FOSFOMYCIN; GLYCOPEPTIDE; LINEZOLID; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BODY FLUID; CHINA; GENERAL HOSPITAL; HUMAN; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS;

EID: 84881257476     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing[S]. Twentyth Informational Supplement, 2010, M100-S20.
2. Weinstein MP, Towns ML, Quartey SM, et al. The Clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults [J]. Clin Infect Dis, 1997, 24(4):584-602.
3. Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in nonvancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05[J]. J Antimicrob Chemother, 2007, 60(4): 788-794.
4. Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [J]. Lancet, 1997, 350 (9092): 1670-1673.
5. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing[S]. Eighteenth Informational Supplement,2008, M100-S18.
6. Jones RN. Microbiological features of vancomycin in the 21st century: minimum Inhibitory concentration creep, Bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains [J]. Clin Infect Dis,2006,42 Suppl 1:s13-s24.
7. Sun W, Chen H, Liu Y, et al. Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China[J]. Antimicrob Agents Chemother, 2009, 53(9): 3642-3649.
8. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children[J]. Clin Infect Dis, 2011, 52 (3): e18-e55.